American Heart Association (AHA)

The American Heart Association (AHA) funds cardiovascular medical research, educates consumers on healthy living and fosters appropriate cardiac care in an effort to reduce disability and deaths caused by cardiovascular disease and stroke. The AHA also is a key resource for the latest cardiology science through its journals and annual meeting.

Statin use may protect patients from subarachnoid hemorrhages
Statins appear to be the most impactful for patients diagnosed with hypertension or cerebrovascular disease.
Women less likely to receive DCD heart transplants
Donation after circulatory death heart transplants are gaining popularity in the United States, but men are much more likely to be selected for one.
Heart attack deaths are way down after decades of breakthroughs—but other risks have skyrocketed
Researchers explored more than 52 years of data, highlighting several key trends in the Journal of the American Heart Association.
Inflammation playing a much bigger role in heart disease evaluations
From new drug therapies and imaging technologies to updated prevention strategies, nearly every aspect of cardiovascular care is starting to embrace the value of coronary inflammation evaluations. Paul Ridker, MD, MPH, discussed the trend in a new interview.
Death from heart disease more common in rural areas—what can cardiologists do?
Rishi Wadhera, MD, detailed new data that show how socioeconomic factors are driving cardiovascular death rates, especially in younger adults.

Statin use may protect patients from subarachnoid hemorrhages

Statins appear to be the most impactful for patients diagnosed with hypertension or cerebrovascular disease.

artificial intelligence AI in healthcare

Women less likely to receive DCD heart transplants

Donation after circulatory death heart transplants are gaining popularity in the United States, but men are much more likely to be selected for one.

Heart attack deaths are way down after decades of breakthroughs—but other risks have skyrocketed

Researchers explored more than 52 years of data, highlighting several key trends in the Journal of the American Heart Association.

Paul Ridker, MD, MPH, Eugene Braunwald Professor of Medicine at Harvard Medical School, and Director of the Center for Cardiovascular Disease Prevention, at Brigham and Women’s Hospital, explains the role of high sensitivity C-reactive protein (hs-CRP) in detecting coronary inflammation and the opportunities to improve outcomes with targeted therapies.

Inflammation playing a much bigger role in heart disease evaluations

From new drug therapies and imaging technologies to updated prevention strategies, nearly every aspect of cardiovascular care is starting to embrace the value of coronary inflammation evaluations. Paul Ridker, MD, MPH, discussed the trend in a new interview.

Rishi Wadhera, MD, MPP, MPhil, associate director of the Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, and associate professor of medicine at Harvard Medical School, Explains a report showing socioeconomic factors are driving increased cardiovascular death rates, especially in younger adults, and urges action to address these health disparities.

Death from heart disease more common in rural areas—what can cardiologists do?

Rishi Wadhera, MD, detailed new data that show how socioeconomic factors are driving cardiovascular death rates, especially in younger adults.

Private equity's influence continues to rise in cardiology—what does that mean for patient care?

Rishi Wadhera, MD, MPP, MPhil, a cardiologist who also specializes in healthcare policy, spoke to Cardiovascular Business about the good, the bad and the unknown when it comes to private equity's role in cardiology.

How anticoagulants may impact a patient’s risk of gastrointestinal bleeding after TAVR

Researchers tracked the rates of major gastrointestinal bleeding in patients with AFib randomized to receive edoxaban or a vitamin K antagonist after a successful TAVR procedure.

Video interview with Mario Gaudino on trends in cardiac surgery.

Veteran surgeon unpacks major changes in the world of cardiac surgery

Mario Gaudino, MD, PhD, spoke to Cardiovascular Business about minimally invasive procedures, the growing interest in clinical trials and other key trends in the world of cardiac surgery.